| Code | Description | Claims | Beneficiaries | Total Paid |
| 83735 |
|
696 |
526 |
$0.00 |
| 90686 |
|
123 |
123 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
198 |
143 |
$0.00 |
| 90677 |
|
12 |
12 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,755 |
1,737 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
770 |
763 |
$0.00 |
| 82728 |
|
341 |
334 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
4,392 |
3,576 |
$0.00 |
| 3079F |
|
132 |
129 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,178 |
1,085 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,632 |
1,389 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
320 |
316 |
$0.00 |
| 81001 |
|
394 |
367 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,707 |
1,392 |
$0.00 |
| 82043 |
|
596 |
577 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
434 |
429 |
$0.00 |
| 83550 |
|
320 |
314 |
$0.00 |
| 3044F |
|
309 |
306 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
54 |
53 |
$0.00 |
| 87340 |
|
107 |
107 |
$0.00 |
| 3074F |
|
658 |
603 |
$0.00 |
| 3075F |
|
238 |
233 |
$0.00 |
| 92250 |
|
17 |
17 |
$0.00 |
| 99443 |
|
38 |
38 |
$0.00 |
| 82607 |
|
174 |
172 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
545 |
539 |
$0.00 |
| 85652 |
|
25 |
25 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,132 |
1,092 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
193 |
190 |
$0.00 |
| 1111F |
|
160 |
149 |
$0.00 |
| 85027 |
|
562 |
514 |
$0.00 |
| 86141 |
|
29 |
27 |
$0.00 |
| 82746 |
|
67 |
66 |
$0.00 |
| 90656 |
|
69 |
69 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
46 |
46 |
$0.00 |
| 3052F |
|
28 |
28 |
$0.00 |
| 97010 |
|
85 |
42 |
$0.00 |
| 99441 |
|
12 |
12 |
$0.00 |
| 86706 |
|
99 |
99 |
$0.00 |
| 90674 |
|
15 |
15 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
32 |
32 |
$0.00 |
| 83540 |
|
326 |
320 |
$0.00 |
| 82570 |
|
201 |
190 |
$0.00 |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
51 |
37 |
$0.00 |
| 84100 |
|
322 |
261 |
$0.00 |
| 82274 |
|
289 |
288 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
540 |
265 |
$0.00 |
| 80061 |
Lipid panel |
1,308 |
1,293 |
$0.00 |
| 3078F |
|
914 |
836 |
$0.00 |
| 86480 |
|
190 |
182 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
271 |
256 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
100 |
100 |
$0.00 |
| 82540 |
|
596 |
577 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,072 |
1,631 |
$0.00 |
| 86703 |
|
334 |
333 |
$0.00 |
| 85610 |
|
399 |
293 |
$0.00 |
| 81003 |
|
16 |
13 |
$0.00 |
| 77062 |
|
59 |
59 |
$0.00 |
| 90653 |
|
30 |
30 |
$0.00 |
| 3051F |
|
38 |
38 |
$0.00 |
| 84439 |
|
24 |
24 |
$0.00 |
| 3077F |
|
235 |
228 |
$0.00 |
| 86705 |
|
39 |
39 |
$0.00 |
| 83970 |
|
13 |
12 |
$0.00 |
| 80076 |
|
57 |
56 |
$0.00 |
| 99442 |
|
45 |
45 |
$0.00 |
| 90750 |
|
30 |
30 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
13 |
13 |
$0.00 |
| 3046F |
|
55 |
54 |
$0.00 |
| 90661 |
|
25 |
25 |
$0.00 |